Key Takeaways
- Sublocade is a once-monthly injection of buprenorphine used to treat moderate to severe opioid use disorder as part of medication-assisted treatment (MAT).
- The medication works by easing cravings and withdrawal while reducing the rewarding effects of other opioids, which gives patients a stable foundation for recovery work.
- Patients typically begin with a short course of oral buprenorphine before transitioning to monthly Sublocade injections, eliminating the need to remember a daily dose.
- Like any medication, Sublocade has potential side effects and is not the right fit for everyone, so the decision to use it should be made with a qualified treatment team.
- Gateway Rehab offers comprehensive opioid addiction treatment, including medication-assisted treatment, across Western Pennsylvania. Reach out to start recovery today.
Understanding Opioid Use Disorder and Why MAT Matters
Opioid use disorder is a chronic medical condition that changes how the brain responds to opioids, making it extremely difficult to stop using through willpower alone. Even after the body clears the substance, cravings, anxiety, and physical discomfort can persist for weeks or months, which is one of the main reasons relapse is so common in early recovery.
Medication-assisted treatment combines FDA-approved medications with counseling and behavioral therapy to address opioid use disorder from both a physical and psychological angle. Medications used in MAT can reduce cravings, ease withdrawal symptoms, and lower the risk of overdose, which gives patients the stability they need to engage fully in therapy and rebuild their lives.
Sublocade is one of several FDA-approved options used in MAT for opioid use disorder.
What Is Sublocade?
Sublocade is the brand name for an extended-release form of buprenorphine that is given as a once-monthly injection under the skin of the abdomen. Buprenorphine itself has been used in opioid addiction treatment for decades, but Sublocade allows patients to receive a steady, controlled dose over the course of a full month rather than taking a daily film or tablet.
A few key points about Sublocade:
- It is delivered subcutaneously by a healthcare provider in a clinical setting
- Each injection slowly releases buprenorphine into the body over about 30 days
- It is intended for patients with moderate to severe opioid use disorder
- It is used alongside counseling and behavioral therapy, not as a stand-alone treatment
Because it is a long-acting injection, Sublocade is dispensed only through certified healthcare providers and pharmacies as part of a federally required safety program.
How Sublocade Supports Opioid Addiction Recovery
Buprenorphine is a partial opioid agonist, meaning it activates the same brain receptors as other opioids but to a much smaller degree. This action helps quiet cravings and prevent withdrawal without producing the same high or risk of overdose. Sublocade delivers a steady level of buprenorphine throughout the month, which supports recovery in several practical ways:
- Stable cravings management: A consistent monthly dose helps avoid the daily peaks and valleys that can occur with oral medication.
- Reduced reward from other opioids: While Sublocade is active, the effects of other opioids are largely blunted, which lowers the incentive to use.
- Better engagement in therapy: When cravings and withdrawal are managed, patients can focus on the counseling and behavioral work that fuels long-term recovery.
- Fewer daily reminders of treatment: Patients do not have to take a daily medication, which can be helpful for privacy, work travel, or busy family schedules.
Daily Medication vs Monthly Sublocade Injection
Many patients who consider Sublocade have already used or considered daily oral buprenorphine products. Both are effective forms of MAT, but they fit different lifestyles.
| Factor | Daily Buprenorphine | Sublocade (Monthly Injection) |
|---|---|---|
| Frequency | Once or twice daily | Once monthly |
| Where it is taken | At home | In a clinical setting |
| Adherence | Depends on remembering each dose | Built in for the full month |
| Flexibility | Easy to stop or adjust | Slowly releases over weeks |
| Best for | Patients new to MAT or who prefer daily flexibility | Patients who want consistent coverage and fewer daily decisions |
Many patients begin with oral buprenorphine to stabilize before transitioning to monthly Sublocade injections. The treatment team will recommend the right path based on each patient's medical history and recovery goals.
Common Patient Concerns and What to Expect
It is normal to have questions before starting any new medication. Some of the most common concerns patients raise about Sublocade injections include:
- Pain at the injection site: Most patients describe mild discomfort that fades within a few days. A small bump may form at the site and is expected.
- Side effects: Possible side effects include constipation, headache, nausea, fatigue, and changes in liver enzymes. The treatment team will monitor patients with regular check-ins and lab work as needed.
- Stopping treatment: Because Sublocade releases buprenorphine slowly, the medication continues to be active for a period after the last injection. Any decision to stop should be made with the treatment team.
- Will it make me feel high? Sublocade is designed to stabilize, not produce euphoria. Most patients describe feeling 'normal' rather than impaired.
These conversations are part of every intake at Gateway Rehab, and the medical team will walk through the full list of risks, benefits, and expectations before treatment begins.
Who May Be a Good Candidate for Sublocade Treatment?
Sublocade may be a strong fit for patients who:
- Have moderate to severe opioid use disorder
- Have already completed a brief stabilization period on oral buprenorphine
- Want consistent, long-acting coverage rather than daily dosing
- Are committed to combining medication with counseling and behavioral therapy
- Do not have certain medical conditions that would make buprenorphine unsafe
Sublocade is not appropriate for everyone. People with certain liver conditions, allergies, or medication interactions may need a different option. A clinical evaluation is the only way to determine the right plan.
How Sublocade Fits Into Gateway Rehab's Treatment Approach
At Gateway Rehab, medication is one piece of a larger continuum. Patients who receive medication-assisted treatment are also connected to counseling, group therapy, family programs, peer support, and continuing care, so recovery is supported on every front.
Each patient receives a personalized treatment plan that considers the substances involved, co-occurring mental health conditions, family circumstances, work or school obligations, and previous treatment history. Sublocade may be part of that plan, or another option may be a better fit.
Reach Out to Start Recovery With Gateway Rehab
Starting opioid recovery is a major step, and you do not have to figure it out alone. With the right medication, therapy, and support system, lasting recovery is achievable.
To learn whether Sublocade or another form of opioid addiction treatment is right for you or a loved one, contact Gateway Rehab. Reach out to start recovery today.
Frequently Asked Questions
What is Sublocade used to treat?
Sublocade is used to treat moderate to severe opioid use disorder in adults who have already been stabilized on oral buprenorphine. It is one option within medication-assisted treatment and is always paired with counseling and behavioral therapy.
Is a Sublocade injection painful?
Most patients describe mild discomfort during the injection that fades within a few days. A small bump at the injection site is expected and resolves on its own.
How long do people stay on Sublocade treatment?
There is no set timeline. Some patients stay on Sublocade for several months, while others continue for a year or longer. The decision is made together with the treatment team based on progress and clinical needs.
Is medication-assisted treatment the same as replacing one drug with another?
No. MAT uses FDA-approved medications at carefully managed therapeutic doses to stabilize the brain so patients can engage in recovery work. SAMHSA and other medical authorities consistently identify MAT as an evidence-based standard of care for opioid use disorder.
